Risk factors for arterial ischemic stroke in children

Journal of Child Neurology

Volumn 15, Issue 5, 2000, Pages 299-307

  Kirkham, Fenella J ^a   Prengler, Mara ^a   Hewes, Deborah K M ^a   Ganesan, Vijeya ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; MASS SCREENING; PRIMARY PREVENTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SICKLE CELL ANEMIA;

EID: 0034044382     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500506     Document Type: Article

References (115)

1. De Vivo DC, Holmes SJ, Dodge PR: Cerebrovascular disease in a pediatric population, letter. Ann Neurol 1977;2:261.
2. Dusser A, Goutieres F, Aicardi J: Ischemic strokes in children. J Child Neurol 1986;1:131-136.
3. Riikonen R, Santavuori P: Hereditary and acquired risk factors for childhood stroke. Neuropediatr 1994;25:227-233.
4. Abram H, Knepper E, Warty VS, Painter MJ: Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke. J Child Neurol 1996;11:276-282.
5. Mancini J, Girard N, Chabrol B, et al: Ischaemic cerebrovascular disease in children: Retrospective study of 35 patients. J Child Neurol 1997;12:193-199.
6. Ganesan V, Kirkham FJ: Recurrence after ischaemic stroke in childhood, abstract. Dev Med Child Neurol 1998;(Suppl 79):7.
7. Roach ES, Riela AR: Pediatric Cerebrovascular Disorders, 2nd ed. Armonk, NY, Futura, 1995.
8. Sacco RL, Benjamin EJ, Broderick JP, et al: American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-1517.
9. Adams RJ, for the STOP Investigators: Prevention of stroke by transfusion in sickle cell disease. N Engl J Med 1998;339:5-11.
10. Martyn CN, Barker DJ, Osmond C: Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 1996;348:1264-1268.
11. Celermajer DS, Adams MR, Clarkson P, et al: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-154.
12. Shirane R, Sato S, Yoshimoto T Angiographic findings of ischaemic stroke in children. Childs Nerv Syst 1992;8:432-436.
13. Chabrier S, Rodesch G, Lasjaunias P, et al: Transient cerebral arteriopathy: A disorder recognized by serial angiograms in children with stroke. J Child Neurol 1998;13:27-32.
14. Ganesan V, Savvy L, Chong WK, Kirkham FJ: Conventional cerebral angiography in the investigation of children with ischaemic stroke. Pediatr Neurol 1999;20:38-42.
15. Lutterman J, Scott M, Nass R, Geva T: Moyamoya syndrome associated with congenital heart disease. Pediatrics 1998;101:57-60.
16. Schievink WI, Mokri B, Piepgras DG, Gittenberger-de Groot AC: Intracranial aneurysms and cervicocephalic arterial dissections associated with congenital heart disease. Neurosurgery 1996;39: 685-690.
17. Ganesan V, Kirkham FJ: Stroke due to arterial disease in a child with congenital heart disease, letter. Arch Dis Child 1997;76:175.
18. Clarkson PM, Gomez MR, Wallace RB, Weidman WH: Central nervous system complications following Blalock-Taussig operation. Pediatrics 1967;39:18-23.
19. Delgado C, Barturen F: Coarctation of the aorta with right aortic arch and isolation of the left innominate artery: A surgical challenge in a patient with collateral posterior brain circulation. J Thorac Cardiovasc Surg 1998;116:657-659.
20. Adams RJ, McKie VC, Carl EM, et al: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997;42:699-704.
21. Kirkham FJ, Watkins K, Hewes DKM, et al: Risk factors for cerebrovascular abnormalities and cognitive problems in sickle cell disease, abstract. Eur J Paediatr Neurol 1997;1:A39.
22. Brown RD Jr, Petty GW, O'Fallon WM, et al: Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 1998;29:2109-2113.
23. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al: Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-294.
24. Kugler S, Anderson B, Cross D, et al: Abnormal cranial magnetic resonance imaging scans in sickle cell disease. Arch Neurol 1993;50:629-635.
25. Kinney TR, Sleeper LA, Wang WC: Silent cerebral infarcts in sickle cell anemia: A risk factor analysis. Pediatrics 1999;103:640-645.
26. Cross HC, Kirkham FJ: Vascular pathologies, in Oxbury J, Duchovny M, Polkey C (eds): Intractable Focal Epilepsy. London, Harcourt-Brace, 2000, pp 171-184.
27. You RX, McNeil JJ, O'Malley HM, et al: Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997;1913-1918.
28. Haffner SM, D'Agostino R, Mykkänen L, et al: Proinsulin and insulin concentrations in relation to carotid wall thickness. Stroke 1998;29:1498-1503.
29. Nowak-Gottl U, Strater R, Heinecke A, et al: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-3682.
30. Koskenvuo M, Kaprio J, Telakivi T, et al: Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987;294:16-19.
31. Bassetti C, Aldrich MS, Chervin RD, Quint D: Sleep apnea in patients with transient ischemic attack and stroke: A prospective study of 59 patients. Neurology 1996;47:1167-1173.
32. Good DC, Henkle JQ, Gelber D, et al: Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996;27:252-259.
33. Samuels MP, Stebbens VA, Davies SC, et al: Sleep-related upper airway obstruction and hypoxaemia in sickle cell disease. Arch Dis Child 1992;67:925-929.
34. Robertson PL, Aldrich MS, Hanash SM, Goldstein GW: Stroke associated with obstructive sleep apnea in a child with sickle cell anemia. Ann Neurol 1988;23:614-616.
35. Davies SC, Stebbens VA, Samuels MP, Southall DP: Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia. Lancet 1989;2:283-284.
36. Heier LA, Carpanzano CR, Mast J, et al: Maternal cocaine abuse: The spectrum of radiologic abnormalities in the neonatal CNS. Am J Neuroradiol 1991;12:951-956.
37. Grau AJ, Buggle F, Becher H, et al: Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies. Neurology 1998;50:196-203.
38. Grau AJ, Buggle F, Ziegler C, et al: Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 1997;28:1724-1729.
39. Brower MC, Rollins N, Roach ES: Basal ganglia and thalamic infarction in children. Cause and clinical features. Arch Neurol 1996;53:1252-1256.
40. Park YD, Belman AL, Kim TS, et al: Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990;28:303-311.
41. Visudtibhan A, Visudhiphan P, Chiemchanya S: Stroke and seizures as the presenting signs of pediatric HIV infection. Pediatr Neurol 1999;20:53-56.
42. Fu M, Wong KS, Lam WW, Wong GW: Middle cerebral artery occlusion after recent Mycoplasma pneuinoniae infection. J Neurol. Sci 1998;157:113-115.
43. Cook PJ, Honeybourne D, Lip GY, et al: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project. Stroke 1998;29:404-410.
44. Fagerberg B, Gnarpe J, Gnarpe H, et al: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999;30:299-305.
45. Fryer RH, Schwobe EP, Woods ML, Rodgers GM: Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 1997;45:168-174.
46. Markus HS, Mendall MA: Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma J Neurol Neurosurg Psychiatry 1998;64:104-107.
47. Ridker PM, Hennekens CH, Stampfer MJ, Wang F: Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998;98:2796-2799.
48. Grau AJ, Eckstein HH, Schafer B, et al: Stroke from internal carotid artery occlusion during mumps infection. J Neurol Sci 1998;155:215-217.
49. Shuper A, Vining EP, Freeman JM: Central nervous system vasculitis after chickenpox - cause or coincidence? Arch Dis Child 1990;65:1245-1248.
50. Ganesan V, Kirkham FJ: Mechanisms of ischaemic stroke after chickenpox. Arch Dis Child 1997;76:522-525.
51. Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: A case-control study. Ann Neurol 1999;45:679-680.
52. Hausler MG, Ramaekers VT, Reul J, et al: Early and late onset manifestations of cerebral vasculitis related to varicella zoster. Neuropediatrics 1998;29:202-207.
53. Schievink WI, Mokri B, Piepgras DG: Spontaneous dissections of the cervicocephalic arteries in childhood and adolescence. Neurology 1994;44:1607-1612.
54. Williams LS, Garg BP, Cohen M, et al: Subtypes of ischemic stroke in children and young adults. Neurology 1997;49:1541-1545.
55. Chabrier S, Husson B, Lasjaunias P, et al: Stroke in childhood: Outcome and recurrence risk by mechanism in 59 patients. J Child. Neurol 2000;15:290-294.
56. Ganesan V, Kirkham FJ: Carotid dissection causing stroke in a child with migraine. BMJ 1997;314:291-292.
57. Kirkham FJ, Amess P, Chong WK, et al: Mechanical trauma of the cord and the posterior cerebral circulation in extrapyramidal cerebral palsy, abstract. Dev Med Child Neurol 1997;39(Suppl 77):25.
58. Grau AJ, Brandt T, Forsting M, et al: Infection-associated cervical artery dissection. Three cases. Stroke 1997;28:453-455.
59. Brandt T, Hausser I, Orberk E, et al: Ultrastructural connective tissue abnormalities in patients with spontaneous cervicocerebral artery dissections. Ann Neurol 1998;44:281-285
60. van den Berg JS, Limburg M, Kappelle LJ, et al: The role of type III collagen in spontaneous cervical arterial dissections. Ann Neurol 1998;43:494-498.
61. Schievink WI, Mokri B, O'Fallon WM: Recurrent spontaneous cervical-artery dissection. N Engl J Med 1994;330:393-397.
62. Gilon D, Buonanno FS, Joffe MM, et al: Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341:8-13.
63. Klotzsch C, Janssen G, Berlit P: Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: Experiences with 111 patients. Neurology 1994;44:1603-1606.
64. Lechat P, Mas JL, Lascault G, et al: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
65. Webster MW, Chancellor AM, Smith HJ, et al: Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
66. Hanna JP, Sun JP, Furlan AJ, et al: Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-786.
67. Ay H, Buonanno FS, Abraham SA, et al: An electrocardiographic criterion for diagnosis of patent foramen ovale associated with ischemic stroke. Stroke 1998;29:1393-1397.
68. Steiner MM, Di Tullio MR, Rundek T, et al: Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
69. Hamann GF, Schatzer-Klotz D, Frohlig G, et al: Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998;50:1423-1428.
70. Barinagarrementeria F, Amaya LE, Cantu C: Causes and mechanisms of cerebellar infarction in young patients. Stroke 1997;28:2400-2404.
71. Bogoussiavsky J, Garazi S, Jeanrenaud X, et al: Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne stroke with paradoxal embolism study group. Neurology 1996;46:1301-1305.
72. Devuyst G, Bogoussiavsky J, Ruchat P, et al: Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-1166.
73. Natowicz M, Kelley RI: Mendelian etiologies of stroke. Ann Neurol 1987;22:175-192.
74. Mintz M, Epstein LG, Koenigsberger MR: Idiopathic childhood stroke is associated with human leukocyte antigen (HLA)-B51. Ann Neurol 1992;31:675-677.
75. Aoyagi M, Ogami K, Matsushima Y, et al: Human leukocyte antigen in patients with moyamoya disease. Stroke 1995;26:415-417.
76. Kitahara T, Okumura K, Semba A, et al: Genetic and immunologic analysis on moya-moya. J Neurol Neurosurg Psychiatry 1982;45:1048-1052.
77. Ikeda H, Sasaki T, Yoshimoto T, et al: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999;64:533-537.
78. Towbin JA, Casey B, Belmont J: Human genetics '99: The cardiovascular system. The molecular basis of vascular disorders. Am J Hum Genet 1999;64:678-684.
79. Grill J, Couanet D, Cappelli C, et al: Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 1999;45:393-396.
80. Schievink WI, Mokri B: Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke 1995;26:1935-1940.
81. Schievink WI, Michels W, Piepgras DG: Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke 1994;25:889-903.
82. Schievink WI, Wijdicks EF, Michels W, et al: Heritable connective tissue disorders in cervical artery dissections: A prospective study. Neurology 1998;50:1166-1169.
83. Lu C-Y, Hou J-W, Wang P-J, et al: Homocystinuria presenting as fatal common carotid artery occlusion. Pediatr Neurol 1996;15:159-162.
84. Cardo E, Campistol J, Vilaseca A, et al: Stroke in infancy in a child with homocystinuria. Dev Med Child Neurol 1999;41:132-135.
85. Perry IJ, Refsum H, Morris RW, et al: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398.
86. Markus HS, Nadira A, Swaminathan R, et al: A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischaemic cerebrovascular disease. Stroke 1997-28:1739-1743.
87. van Beynum IM, Smeitink JA, den Heijer M, et al: Hyperhomocysteinemia: A risk factor for ischemic stroke in children. Circulation 1999;99:2070-2072.
88. Cardo E, Vilaseca MA, Campistol J, et al: Evaluation of hyperhomocysteinemia in children with stroke. Eur J Paediatr Neurol 1999;3:113-117.
89. Prengler M, Sturt N, Krywawych S, et al: The homozygous thermolabile variant of the methylene tetrahydrofolate reductase gene: A risk factor for cerebrovascular disease in childhood, abstract. Dev Med Child Neurol 1998;Suppl 79:10.
90. Cardo E, Monrós E, Colomé C, et al: Children with stroke: Polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000;15:295-298.
91. Houston PE, Rana S, Sekhsaria S, et al: Homocysteine in sickle cell disease: Relationship to stroke. Am J Med 1997;103:192-196.
92. Andrade FL, Annichino-Bizzacchi JM, Saad ST, et al: Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 1998;59:46-50.
93. Woodside JV, Yarnell JW, McMaster D, et al: Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: A double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr 1998;67:858-866.
94. Jacques PF, Selhub J, Bostom AG, et al: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454.
95. deVeber G, Monagle P, Chan A, et al: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-1543.
96. Ganesan V, McShane MA, Liesner R, et al: Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatr 1998;65:508-511.
97. Liesner R, Mackie I, Cookson J, et al: Prothrombotic changes in children with sickle cell disease: Relationships to cerebrovascular disease and transfusion. Br J Haematol 1998;103:1037-1044.
98. Thorarensen O, Ryan S, Hunter J, Younkin DP: Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997;42:372-375.
99. Ganesan V, Kelsey H, Cookson J, et al: Activated protein C resistance in childhood stroke, letter. Lancet 1996;347:260.
100. Zenz W, Bodo Z, Plotho J, et al: Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke. Thromb Haemost 1998;80:763-766.
101. Longstreth WT Jr, Rosendaal FR, Siscovick DS, et al: Risk of stroke in young women and two prothrombotic mutations: Factor V Leiden and prothrombin gene variant (G20210A). Stroke 1998;29:577-580.
102. Lalouschek W, Aull S, Series W, et al: C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: A case-control study. Thromb Res 1999;93:61-69.
103. Kahn MJ, Scher C, Rozans M, et al: Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease. Am J Hematol 1997;54:12-15.
104. Gaustadnes M, Rudiger N, Ingerslev J: The 20210 A allele of the prothrombin gene is not a risk factor for juvenile stroke in the Danish population. Blood Coag Fibrinolysis 1998;9:663-664.
105. Mandel H, Brenner B, Berant M, et al: Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. N Engl J Med 1996;334:763-768.
106. Tanne D, Triplett DA, Levine SR: Antiphospholipid-protein antibodies and ischemic stroke: Not just cardiolipin any more. Stroke 1998;29:1755-1758.
107. Verro P, Levine SR, Tietjen GE: Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 1998;29: 2245-2253.
108. D'Olhaberriague L, Levine SR, Salowich-Palm L, et al: Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases. Neurology 1998;51:1376-1380.
109. Metz LM, Edworthy S, Mydlarski R, Fritzler MJ: The frequency of phospholipid antibodies in an unselected stroke population. Can J Neurol Sci 1998;25:64-69.
110. Levine SR, Salowich-Palm L, Sawaya KL, et al: IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thromboocclusive events and death. A prospective cohort study. Stroke 1997;28:1660-1665.
111. Tanne D, D'Olhaberriague L, Schultz LR, et al: Anticardiolipin antibodies and their associations with cerebrovascular risk factors. Neurology 1999;52:1368-1373.
112. Carhuapoma JR, Mitsias P, Levine SR: Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363-2369.
113. Phornphutkul C, Rosenthal A, Nadas A, Berenberg W: Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol 1973;32:329-334.
114. Cottrill CM, Kaplan S: Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child 1973;125:484-487.
115. Hartfield DS, Lowry NJ, Keene DL, Yager JY: Iron deficiency: A cause of stroke in infants and children. Pediatr Neurol 1997;16: 50-53.